Exeter announces new £3.4 million global funding for solutions to antifungal drug resistance

Researchers working on antifungal resistance solutions are being encouraged to apply to a £3.4 million fund led by the University of Exeter, UK government funding. The new FAILSAFE (Fungal AMR Innovations for LMICS: Solutions and Access For Everyone) fund is being launched by the University of Exeter’s MRC Centre for Medical Mycology in partnership with the UK Department of Health and Social Care’s Global AMR Innovation Fund (GAMRIF). The fund aims to address the urgent need for solutions to life-threatening fungal diseases, which take as many lives annually as TB or malaria. The increasing frequency of antifungal drug resistance among fungi in the natural environment and in patients undergoing hospital treatment means even fewer drugs are effective. The FAILSAFE project will distribute its funds to innovative projects that deliver products or solutions for AFR, led by researchers from across the globe.